Prestige Consumer Healthcare Price to Sales Ratio 2010-2023 | PBH
Prestige Consumer Healthcare P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2024-05-02 | 71.26 | 3.15 | |
2023-12-31 | 61.22 | $22.65 | 2.70 |
2023-09-30 | 57.19 | $22.50 | 2.54 |
2023-06-30 | 59.43 | $22.54 | 2.64 |
2023-03-31 | 62.63 | $22.44 | 2.79 |
2022-12-31 | 62.60 | $21.96 | 2.85 |
2022-09-30 | 49.83 | $21.86 | 2.28 |
2022-06-30 | 58.80 | $21.54 | 2.73 |
2022-03-31 | 52.94 | $21.39 | 2.48 |
2021-12-31 | 60.65 | $20.84 | 2.91 |
2021-09-30 | 56.11 | $20.17 | 2.78 |
2021-06-30 | 52.10 | $19.42 | 2.68 |
2021-03-31 | 44.08 | $19.02 | 2.32 |
2020-12-31 | 34.87 | $19.07 | 1.83 |
2020-09-30 | 36.42 | $19.04 | 1.91 |
2020-03-31 | 36.68 | $18.81 | 1.95 |
2019-12-31 | 40.50 | $18.53 | 2.19 |
2019-09-30 | 34.69 | $18.29 | 1.90 |
2019-06-30 | 31.68 | $18.23 | 1.74 |
2019-03-31 | 29.91 | $18.36 | 1.63 |
2020-06-30 | 37.56 | $18.53 | 2.03 |
2018-12-31 | 30.88 | $18.79 | 1.64 |
2018-09-30 | 37.89 | $19.22 | 1.97 |
2018-06-30 | 37.91 | $19.45 | 1.95 |
2018-03-31 | 33.31 | $19.45 | 1.71 |
2017-12-31 | 43.86 | $19.18 | 2.29 |
2017-09-30 | 49.47 | $18.19 | 2.72 |
2017-06-30 | 52.16 | $17.40 | 3.00 |
2017-03-31 | 54.88 | $16.57 | 3.31 |
2016-12-31 | 51.46 | $15.97 | 3.22 |
2016-09-30 | 47.68 | $15.67 | 3.04 |
2016-06-30 | 54.72 | $15.51 | 3.53 |
2016-03-31 | 52.73 | $15.18 | 3.47 |
2015-12-31 | 50.85 | $14.88 | 3.42 |
2015-09-30 | 44.60 | $14.86 | 3.00 |
2015-06-30 | 45.67 | $14.43 | 3.16 |
2015-03-31 | 42.36 | $13.58 | 3.12 |
2014-12-31 | 34.29 | $12.70 | 2.70 |
2014-09-30 | 31.97 | $11.72 | 2.73 |
2014-06-30 | 33.47 | $11.47 | 2.92 |
2014-03-31 | 26.91 | $11.63 | 2.31 |
2013-12-31 | 35.36 | $12.01 | 2.95 |
2013-09-30 | 29.75 | $12.40 | 2.40 |
2013-03-31 | 25.37 | $12.08 | 2.10 |
2012-12-31 | 19.78 | $11.79 | 1.68 |
2012-09-30 | 16.75 | $11.41 | 1.47 |
2012-06-30 | 15.62 | $10.35 | 1.51 |
2012-03-31 | 17.26 | $9.56 | 1.81 |
2013-06-30 | 28.78 | $8.80 | 3.27 |
2011-12-31 | 11.13 | $7.98 | 1.40 |
2011-09-30 | 8.94 | $7.67 | 1.17 |
2011-06-30 | 12.68 | $7.15 | 1.77 |
2011-03-31 | 11.36 | $6.69 | 1.70 |
2010-12-31 | 11.80 | $6.12 | 1.93 |
2010-09-30 | 9.77 | $5.80 | 1.69 |
2010-06-30 | 6.99 | $5.85 | 1.20 |
2010-03-31 | 8.89 | $5.84 | 1.52 |
2009-12-31 | 7.76 | $5.65 | 1.37 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $3.531B | $1.128B |
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $184.433B | 24.21 |
Stryker (SYK) | United States | $124.840B | 29.94 |
Boston Scientific (BSX) | United States | $108.315B | 33.74 |
Medtronic (MDT) | Ireland | $107.408B | 15.20 |
EssilorLuxottica (ESLOY) | France | $98.531B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.055B | 0.00 |
Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
ResMed (RMD) | United States | $31.587B | 29.66 |
Terumo (TRUMY) | Japan | $24.910B | 35.18 |
Koninklijke Philips (PHG) | Netherlands | $24.851B | 19.25 |
Zimmer Biomet Holdings (ZBH) | United States | $24.565B | 15.81 |
Baxter (BAX) | United States | $20.486B | 14.94 |
Insulet (PODD) | United States | $11.923B | 62.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.553B | 0.00 |
Demant (WILYY) | Denmark | $10.525B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.816B | 23.28 |
BellRing Brands (BRBR) | United States | $7.269B | 39.08 |
Haemonetics (HAE) | United States | $4.679B | 23.93 |
Lantheus Holdings (LNTH) | United States | $4.620B | 11.93 |
Perrigo (PRGO) | Ireland | $4.458B | 12.75 |
GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
Envista Holdings (NVST) | United States | $3.394B | 14.01 |
Green Thumb Industries (GTBIF) | United States | $2.781B | 88.13 |
QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
Neogen (NEOG) | United States | $2.653B | 25.52 |
TG Therapeutics (TGTX) | United States | $2.454B | 69.04 |
ICU Medical (ICUI) | United States | $2.395B | 17.87 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.117B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.911B | 0.00 |
Owens & Minor (OMI) | United States | $1.839B | 17.65 |
Verano Holdings (VRNOF) | United States | $1.731B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.47 |
InMode (INMD) | Israel | $1.448B | 7.50 |
National Vision Holdings (EYE) | United States | $1.386B | 43.17 |
AdaptHealth (AHCO) | United States | $1.337B | 10.06 |
AtriCure (ATRC) | United States | $1.198B | 0.00 |
Warby Parker (WRBY) | United States | $1.187B | 0.00 |
Canopy Growth (CGC) | Canada | $1.147B | 0.00 |
MacroGenics (MGNX) | United States | $0.973B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.792B | 0.00 |
Evolus (EOLS) | United States | $0.790B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.743B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.673B | 14.54 |
Phibro Animal Health (PAHC) | United States | $0.662B | 14.34 |
Quanterix (QTRX) | United States | $0.631B | 0.00 |
Jin Medical (ZJYL) | China | $0.563B | 0.00 |
Valneva SE (VALN) | France | $0.527B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.513B | 0.00 |
PetIQ (PETQ) | United States | $0.497B | 18.54 |
Surmodics (SRDX) | United States | $0.474B | 29.76 |
ZimVie (ZIMV) | United States | $0.422B | 25.83 |
Biote (BTMD) | United States | $0.421B | 4.01 |
OraSure Technologies (OSUR) | United States | $0.408B | 6.75 |
Aurora Cannabis (ACB) | Canada | $0.401B | 0.00 |
Zynex (ZYXI) | United States | $0.374B | 51.17 |
Viemed Healthcare (VMD) | United States | $0.324B | 32.12 |
Cerus (CERS) | United States | $0.318B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.244B | 15.08 |
Veru (VERU) | United States | $0.218B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
Omeros (OMER) | United States | $0.197B | 0.00 |
High Tide (HITI) | Canada | $0.174B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.168B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.141B | 71.00 |
InterCure (INCR) | Israel | $0.135B | 22.77 |
FitLife Brands (FTLF) | United States | $0.128B | 20.56 |
MariMed (MRMD) | United States | $0.114B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.112B | 0.00 |
Fonar (FONR) | United States | $0.101B | 8.70 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Brainsway (BWAY) | Israel | $0.093B | 0.00 |
Chimerix (CMRX) | United States | $0.085B | 0.00 |
Safety Shot (SHOT) | United States | $0.068B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.55 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.64 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Agape ATP (ATPC) | $0.023B | 0.00 | |
Flora Growth (FLGC) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.015B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |